Ranolazine (Standard), CAS 95635-55-5

Product Description: Ranolazine (Standard) is the analytical standard of Ranolazine. This product is intended for research and analytical applications. Ranolazine (CVT 303) is an anti-angina drug that achieves its effects by inhibiting the late phase of inward sodium current (INa and IKr with IC50 values of 6 μM and 12 μM, respectively) without affecting heart rate or blood pressure (BP)[1][2]. Ranolazine is also a partial fatty acid oxidation (FAO) inhibitor[3]. Antianginal agent.

Formula: N/A

References: [1]Keating GM. Ranolazine: a review of its use as add-on therapy in patients with chronic stable angina pectoris. Drugs. 2013 Jan;73(1):55-73./[2]Wang WQ, et al. Antitorsadogenic effects of ({+/-})-N-(2,6-dimethyl-phenyl)-(4[2-hydroxy-3-(2-methoxyphenoxy)propyl]-1-piperazine (ranolazine) in anesthetized rabbits. J Pharmacol Exp Ther. 2008 Jun;325(3):875-81./[3]Zacharowski K, et al. Ranolazine, a partial fatty acid oxidation inhibitor, reduces myocardial infarct size and cardiac troponin T release in the rat. Eur J Pharmacol. 2001 Apr 20;418(1-2):105-10.

CAS Number: 95635-55-5

Molecular Weight: N/A

Research Area: Cardiovascular Disease; Cancer

Target: Calcium Channel;Sodium Channel

• Artikelnummer: MEXHY-B0280R-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-B0280R-0
• Green Labware: Nein
• Verpackungseinheit: Get quote
• Mengeneinheit: STK